Neutrophilic Granule Protein Is a Novel Murine LPS Antagonist
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Neutrophilic granule protein (NGP) was previously reported as a granular protein of neutrophils in mouse, but the function has not been known clearly. We found the presence of the possible signal peptide in NGP and validated this protein is circulating in the bloodstream. In our findings, NGP is being modified post-translationally in Golgi apparatus and endoplasmic reticulum, which is a universal character of secretory molecules with a signal peptide. The secreted NGP protein could be detected both in vitro and in vivo. NGP has sequence similarity with an antimicrobial protein cathelicidin, and we observed the aspect of inflammation of NGP. Interestingly, NGP interacts with the complex of LPS and LPS binding protein (LBP). This interaction blocks the binding of the complex of LPS and LBP to TLR4 and the downstream inflammatory signals. Furthermore, the inhibitory function of NGP against the inflammatory effect of LPS could be observed in both in vitro and in vivo. With these findings, we report NGP is a novel secretory protein to mask LPS and inhibit its function.
Abstract
Neutrophilic granule protein (NGP) was previously reported as a granular protein of neutrophils in mouse, but the function has not been known clearly. We found the presence of the possible signal peptide in NGP and validated this protein is circulating in the bloodstream. In our findings, NGP is being modified post-translationally in Golgi apparatus and endoplasmic reticulum, which is a universal character of secretory molecules with a signal peptide. The secreted NGP protein could be detected both in vitro and in vivo. NGP has sequence similarity with an antimicrobial protein cathelicidin, and we observed the aspect of inflammation of NGP. Interestingly, NGP interacts with the complex of LPS and LPS binding protein (LBP). This interaction blocks the binding of the complex of LPS and LBP to TLR4 and the downstream inflammatory signals. Furthermore, the inhibitory function of NGP against the inflammatory effect of LPS could be observed in both in vitro and in vivo. With these findings, we report NGP is a novel secretory protein to mask LPS and inhibit its function.
참고문헌 (14)
- Gazzano-Santoro H, "High-affinity binding of the bactericidal", permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide, 1992, pp.60, 4754~4761
- Shafer WM, "Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate", Infect Immun, 45, pp.29~35 (1984)
- Lehrer RI, "Defensins: antimicrobial and cytotoxic peptides of mammalian cells", Annu Rev Immunol, 11, pp.105~128 (1993)
- Pereira HA, "Synthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes", Proc Natl Acad Sci U S A, 90, pp.4733~4737 (1993)
- Hirata M, "Investigation of endotoxin binding cationic proteins from granulocytes; agglutination of erythrocytes sensitized with Re-LPS", Adv Exp Med Biol, 256, pp.287~299 (1990)
- Larrick JW, "Antimicrobial activity of rabbit CAP18-derived peptides", Antimicrob Agents Chemother, 37, pp.2534~2539 (1993)
- Akira S, "Toll-like receptor signalling", Nat Rev Immunol, 4, pp.499~511 (2004)
- Chow JC, "Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction", J Biol Chem, 274, pp.10689~10692 (1999)
- Cohen J, "The immunopathogenesis of sepsis", Nature, 420, pp.885~891 (2002)
- Pugin J, "Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14", Proc Natl Acad Sci U S A, 90, pp.2744~2748 (1993)
- Raetz CR, "Lipopolysaccharide endotoxins", Annu Rev Biochem, 71, pp.635~700 (2002)
- Moscinski LC, "Molecular cloning of a novel myeloid granule protein", J Cell Biochem, 59, pp.431~442 (1995)
- Gombart AF, "Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C", EBP epsilon and PU.1, 2003, pp.101, 3265~3273
- Huang J, "Intravenous administration of Gr-1+CD11b+ myeloid cells increases neovascularization and improves cardiac function after heart infarction", Int J Cardiol, 168, pp.1702~1705 (2013)